259 related articles for article (PubMed ID: 9792543)
1. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.
Nielsen MF; Basu R; Wise S; Caumo A; Cobelli C; Rizza RA
Diabetes; 1998 Nov; 47(11):1735-47. PubMed ID: 9792543
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
3. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
[TBL] [Abstract][Full Text] [Related]
4. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
Basu A; Caumo A; Bettini F; Gelisio A; Alzaid A; Cobelli C; Rizza RA
Diabetes; 1997 Mar; 46(3):421-32. PubMed ID: 9032098
[TBL] [Abstract][Full Text] [Related]
5. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes.
Basu R; Basu A; Johnson CM; Schwenk WF; Rizza RA
Diabetes; 2004 Aug; 53(8):2042-50. PubMed ID: 15277384
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
7. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
8. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.
Adkins A; Basu R; Persson M; Dicke B; Shah P; Vella A; Schwenk WF; Rizza R
Diabetes; 2003 Sep; 52(9):2213-20. PubMed ID: 12941759
[TBL] [Abstract][Full Text] [Related]
9. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.
Basu A; Basu R; Shah P; Vella A; Johnson CM; Nair KS; Jensen MD; Schwenk WF; Rizza RA
Diabetes; 2000 Feb; 49(2):272-83. PubMed ID: 10868944
[TBL] [Abstract][Full Text] [Related]
10. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
Vella A; Shah P; Basu R; Basu A; Holst JJ; Rizza RA
Diabetes; 2000 Apr; 49(4):611-7. PubMed ID: 10871199
[TBL] [Abstract][Full Text] [Related]
12. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA
Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
[TBL] [Abstract][Full Text] [Related]
14. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
Lewis GF; Carpentier A; Vranic M; Giacca A
Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
[TBL] [Abstract][Full Text] [Related]
15. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
[TBL] [Abstract][Full Text] [Related]
16. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.
Turk D; Alzaid A; Dinneen S; Nair KS; Rizza R
J Clin Invest; 1995 Feb; 95(2):755-62. PubMed ID: 7860757
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
[TBL] [Abstract][Full Text] [Related]
19. Insulin effect on leucine kinetics in type 2 diabetes mellitus.
Halvatsiotis PG; Turk D; Alzaid A; Dinneen S; Rizza RA; Nair KS
Diabetes Nutr Metab; 2002 Jun; 15(3):136-42. PubMed ID: 12173727
[TBL] [Abstract][Full Text] [Related]
20. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
Boden G; Chen X; Capulong E; Mozzoli M
Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
